Robert M. Weisbrod
- Physiology top 2%
- Molecular Biology top 10%
- Cardiology and Cardiovascular Medicine top 2%
- Biochemistry top 1%
- Immunology top 10%
- Co-authors
- Richard A. CohenTakeshi AdachiVictoria M. BolotinaDavid R. PimentelJia YingBelay TesfamariamChristian SchöneichVictor S. Sharov
- Topics
- Nitric Oxide and Endothelin Effects (24 papers)Cardiovascular Disease and Adiposity (6 papers)Eicosanoids and Hypertension Pharmacology (6 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Robert M. Weisbrod
47 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Physiology 1.3k
- Molecular Biology 1.2k
- Cardiology and Cardiovascular Medicine 955
- Biochemistry 381
- Immunology 348
Countries citing papers authored by Robert M. Weisbrod
This map shows the geographic impact of Robert M. Weisbrod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Weisbrod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Weisbrod more than expected).
Fields of papers citing papers by Robert M. Weisbrod
This network shows the impact of papers produced by Robert M. Weisbrod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Weisbrod. The network helps show where Robert M. Weisbrod may publish in the future.
Co-authorship network of co-authors of Robert M. Weisbrod
This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Weisbrod. A scholar is included among the top collaborators of Robert M. Weisbrod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Weisbrod. Robert M. Weisbrod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 1 | |
| 3 | 35 | |
| 4 | 13 | |
| 5 | 105 | |
| 6 | 35 | |
| 7 | 42 | |
| 8 | 91 | |
| 9 | 52 | |
| 10 | 26 | |
| 11 | 51 | |
| 12 | 28 | |
| 13 | 49 | |
| 14 | 93 | |
| 15 | 56 | |
| 16 | 36 | |
| 17 | 83 | |
| 18 | 14 | |
| 19 | 24 | |
| 20 | 32 |
About Robert M. Weisbrod
Robert M. Weisbrod is a scholar working on Physiology, Biochemistry and Cardiology and Cardiovascular Medicine, having authored 48 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (24 papers), Cardiovascular Disease and Adiposity (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). The work is most often cited by research in Biochemistry (381 citations), Physiology (1.3k citations) and Cardiology and Cardiovascular Medicine (955 citations). Robert M. Weisbrod has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Richard A. Cohen, Takeshi Adachi, Victoria M. Bolotina, David R. Pimentel, Jia Ying, Belay Tesfamariam, Christian Schöneich, Victor S. Sharov, Marion Gericke and Mohammad Ali Yaghoubi. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.